Free Trial
NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

Nutriband logo
$5.07 +0.52 (+11.43%)
As of 01/3/2025 05:39 PM Eastern

About Nutriband Stock (NASDAQ:NTRB)

Key Stats

Today's Range
$4.55
$5.16
50-Day Range
$3.85
$6.35
52-Week Range
$2.22
$9.60
Volume
55,961 shs
Average Volume
36,681 shs
Market Capitalization
$56.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Nutriband Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
5th Percentile Overall Score

NTRB MarketRank™: 

Nutriband scored higher than 5% of companies evaluated by MarketBeat, and ranked 934th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Nutriband.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutriband is -7.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutriband is -7.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nutriband has a P/B Ratio of 5.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.45% of the float of Nutriband has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutriband has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutriband has recently increased by 83.06%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nutriband does not currently pay a dividend.

  • Dividend Growth

    Nutriband does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.45% of the float of Nutriband has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutriband has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutriband has recently increased by 83.06%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nutriband has a news sentiment score of -0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Nutriband this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutriband insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    54.09% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.70% of the stock of Nutriband is held by institutions.

  • Read more about Nutriband's insider trading history.
Receive NTRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

NTRB Stock News Headlines

Nutriband Issues Letter to Shareholders
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Nutriband (NASDAQ:NTRB) Shares Up 1.5% - What's Next?
See More Headlines

NTRB Stock Analysis - Frequently Asked Questions

Nutriband's stock was trading at $4.71 at the beginning of the year. Since then, NTRB shares have increased by 7.6% and is now trading at $5.07.
View the best growth stocks for 2025 here
.

Nutriband Inc. (NASDAQ:NTRB) issued its quarterly earnings results on Monday, December, 13th. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.11. The company had revenue of $0.28 million for the quarter, compared to analysts' expectations of $0.50 million. Nutriband had a negative net margin of 338.51% and a negative trailing twelve-month return on equity of 54.49%.

Shares of Nutriband split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were distributed to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR).

Company Calendar

Last Earnings
12/13/2021
Today
1/05/2025
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NTRB
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-5,490,000.00
Net Margins
-338.51%
Pretax Margin
-338.46%

Debt

Sales & Book Value

Annual Sales
$2.02 million
Book Value
$1.01 per share

Miscellaneous

Free Float
6,314,000
Market Cap
$56.31 million
Optionable
Not Optionable
Beta
0.99
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:NTRB) was last updated on 1/5/2025 by MarketBeat.com Staff
From Our Partners